CTCFL and malignant colon neoplasm: Among candidate genes, we focused on CTCFL/BORIS, which has been described as a cancer-testis (CT) antigen, since CTCFL/BORIS was preferentially expressed in side population cells derived from colon cancer cell line SW480.